The different tumor types also had different effects on CD26 expression: CD26 expression was unchanged when LGR5+ cells were targeted, was upregulated on targeting of LGR6+ cells, and was downregulated by targeting LRIG1+ cells. The gene discussed is LGR5; the disease is neoplasm.